Participation of Older Adults in Clinical Trials for New Drug Applications and Biologics License Applications From 2010 Through 2019

IMPORTANCE: Older age may be accompanied by changes in the pharmacokinetics or pharmacodynamics or both of medications that can result in altered safety and efficacy profiles. OBJECTIVE: To assess representation of older adults in clinical trials of new drug applications (NDAs) and biologics license...

Descripción completa

Detalles Bibliográficos
Autores principales: Lau, S. W. Johnny, Huang, Yue, Hsieh, Julie, Wang, Shenggang, Liu, Qi, Slattum, Patricia W., Schwartz, Janice B., Huang, Shiew-Mei, Temple, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9568796/
https://www.ncbi.nlm.nih.gov/pubmed/36239939
http://dx.doi.org/10.1001/jamanetworkopen.2022.36149

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9568796/
https://www.ncbi.nlm.nih.gov/pubmed/36239939
http://dx.doi.org/10.1001/jamanetworkopen.2022.36149

Ejemplares similares